Unknown

Dataset Information

0

Both Amyloid-? Peptide and Tau Protein Are Affected by an Anti-Amyloid-? Antibody Fragment in Elderly 3xTg-AD Mice.


ABSTRACT: Alzheimer's disease (AD) is the most common dementia worldwide. According to the amyloid hypothesis, the early accumulation of the A?-peptide triggers tau phosphorylation, synaptic dysfunction, and eventually neuronal death leading to cognitive impairment, as well as behavioral and psychological symptoms of dementia. ScFv-h3D6 is a single-chain variable fragment that has already shown its ability to diminish the amyloid burden in 5-month-old 3xTg-AD mice. However, tau pathology is not evident at this early stage of the disease in this mouse model. In this study, the effects of scFv-h3D6 on A? and tau pathologies have been assessed in 22-month-old 3xTg-AD mice. Briefly, 3xTg-AD female mice were treated for 2 weeks with scFv-h3D6 and compared with 3xTg-AD and non-transgenic (NTg) mice treated with PBS. The treatment with scFv-h3D6 was unequivocally effective in reducing the area of A? staining. Furthermore, a tendency for a reduction in tau levels was also observed after treatment that points to the interplay between A? and tau pathologies. The pro-inflammatory state observed in the 3xTg-AD mice did not progress after scFv-h3D6 treatment. In addition, the treatment did not alter the levels of apolipoprotein E or apolipoprotein J. Thus, a 2-week treatment with scFv-h3D6 was able to reduce AD-like pathology in elderly 3xTg-AD female mice.

SUBMITTER: Roda AR 

PROVIDER: S-EPMC7554787 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice.

Roda Alejandro R AR   Montoliu-Gaya Laia L   Serra-Mir Gabriel G   Villegas Sandra S  

International journal of molecular sciences 20200910 18


Alzheimer's disease (AD) is the most common dementia worldwide. According to the amyloid hypothesis, the early accumulation of the Aβ-peptide triggers tau phosphorylation, synaptic dysfunction, and eventually neuronal death leading to cognitive impairment, as well as behavioral and psychological symptoms of dementia. ScFv-h3D6 is a single-chain variable fragment that has already shown its ability to diminish the amyloid burden in 5-month-old 3xTg-AD mice. However, tau pathology is not evident at  ...[more]

Similar Datasets

| S-EPMC5719023 | biostudies-literature
| S-EPMC3979575 | biostudies-literature
| S-EPMC5915484 | biostudies-literature
| S-EPMC4096128 | biostudies-literature
| S-EPMC6562169 | biostudies-literature
| S-EPMC11002285 | biostudies-literature
| S-EPMC7902954 | biostudies-literature
| S-EPMC9131098 | biostudies-literature
| S-EPMC5651359 | biostudies-literature
| S-EPMC4735736 | biostudies-literature